Astria Therapeutics, Inc. logo

Astria Therapeutics, Inc.

95 employees · est. 2008 · Boston, United States

VS
Evommune logo

Evommune

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

69 employees · est. 2020 · Palo Alto, United States

Astria Therapeutics, Inc. is the older company (2008 vs 2020).

Side-by-Side Comparison

Astria Therapeutics, Inc. Evommune
Founded
2008 older 2020
Headquarters
Boston, United States Palo Alto, United States
Employees
95 69
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Post Ipo Equity Unknown
Total Funding
$546.31M $493.00M
Funding Rounds
15 6
Services
Not tracked yet Discovery and development of therapies for chronic inflammatory diseases, Pipeline advancement of product candidates, Hosting webinars and sharing scientific insights
Target Customers
Not tracked yet Patients with chronic inflammatory diseases, Healthcare professionals
Taxonomy
Therapeutics, Hereditary Angioedema, Rare Diseases, Immunological Diseases, Patient-centric, Life-changing Therapies, Medical Research, Healthcare Innovation, Patient Advocacy Chronic Inflammatory Diseases, Innovative Therapies, Tissue-Based Approach, Transformative Medicines, Disease Progression Prevention, Inflammatory Disorders, Best-in-Class Profiles, Patient Care, Research And Development, Symptom Management, Healthcare Innovation, Therapeutic Development, Pipeline Development
Website
astriatx.com evommune.com
Astria Therapeutics, Inc. logo

About Astria Therapeutics, Inc.

Astria Therapeutics, Inc. is a biopharmaceutical company founded in 2008 and based in the United States. Specializing in Hereditary Angioedema (HAE) and rare allergic and immunological diseases, the company's mission is to bring life-changing therapies to patients and families. The company's last in...

Evommune logo

About Evommune

Evommune, founded in 2020, is a pioneering company in the fields of Biotechnology, Health Care, and Life Sciences, based in the United States. The company is making strides in addressing the pervasive challenge of chronic inflammation, which affects millions globally and is a precursor to numerous s...

We will tell you when either one moves

BounceWatch watches Astria Therapeutics, Inc. and Evommune for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Astria Therapeutics, I... and Evommune — by email.

Frequently Asked Questions

Astria Therapeutics, Inc.. Evommune — Developing innovative therapies that target key drivers of chronic inflammatory diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Astria Therapeutics, Inc. has raised $546.31M while Evommune has raised $493.00M.
Astria Therapeutics, Inc. and Evommune operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Astria Therapeutics, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Astria Therapeutics, Inc. on 12 Sep 2024, and Evommune on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy